Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Progress Reports: University of North Carolina-Chapel Hill: Development and Application of Biomarkers of Exposure

Superfund Research Program

Development and Application of Biomarkers of Exposure

Project Leader: Stephen M. Rappaport (University of California-Berkeley)
Grant Number: P42ES005948
Funding Period: 1995 - 2011

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Video page

Progress Reports

Year:   2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995 

Project accomplishments involved work related to the production of benzene oxide (BO) from metabolism of benzene in rodents and humans. The prevailing hypothesis of benzene-induced leukemogenesis has focused almost exclusively upon the phenolic metabolites, catechol and hydroquinone, and their oxidation products, 1,2- and 1,4-benzoquinone (BQ). An attractive feature of this hypothesis is the plausibility of transport of the BQ precursors from the liver to the bone marrow where they can be activated to the toxic quinones by peroxidases. It was thought that BO was too reactive to escape the hepatocyte. However, the discovery of BO-Hb in the blood of animals dosed with benzene called this notion into question and motivated the current focus upon BO. Project investigators confirmed that BO was present in the blood of rats dosed with benzene and that BO was surprisingly stable in human, rat and mouse blood with half-lives of 6-8 min. To investigate the disposition of BO more thoroughly in humans, sensitive assays for adducts of BO with Hb and albumin in blood were developed. Researchers found significant correlation between benzene exposure and adduct levels in both rodents and humans. Adduct measurements were used to suggest that up to 40% of the systemic BO dose reached the bone marrow. Since BO is mutagenic and carcinogenic in newborn mice, it should be considered a possible contributor to the hematotoxic and genotoxic effects associated with benzene.

to Top